Skip to main content
APLS logo

APLS

Apellis Pharmaceuticals, Inc.
$41.03 +0.00 (+0.00%) At close · May 15
Market Cap
$5.25B
Shares
128,021,277

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 327
Total Value: $6,500,053,954
Total Shares: 161,572,313
Showing 1–100 of 345 holdings by value · page 1 of 4

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 326 13F filers · Δ vs Dec 31, 2025
Top Holder
9.9%
Jun 2023 → Mar 2026 · range 9.0% – 13.7%
+0.2 pts
Top 5
35.9%
Jun 2023 → Mar 2026 · range 35.9% – 45.5%
−4.2 pts
Top 10
52.3%
Jun 2023 → Mar 2026 · range 52.3% – 60.8%
−8.3 pts
HHI
376
Jun 2023 → Mar 2026 · range 376 – 534
Broadly held−80

Quarterly Activity

vs Dec 31, 2025
New
125
Increased
92
Decreased
75
Sold Out
82
Unchanged
35
Holder count: +43
Institutional value: +97.5%
Shares held: +23.3%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 345
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1492422 CUSIP 03753U106 13F (30d) 2 filings 2 filers Visit website